Treatments
546 articles
Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers
Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.
Adding A Noninvasive Surgical Technique to Standard Treatment for Locally Advanced Pancreatic Cancer
A clinical trial compares standard treatment plus irreversible electroporation to standard treatment alone for locally advanced pancreatic cancer.
Radiation and Chemotherapy to Make Pancreatic Cancer Surgically Removable
Can a combination of radiation and chemotherapy make pancreatic tumors that are borderline removeable better candidates for surgery? A clinical trial looks at this question.
CRISPR: A New Tool to Help Understand Cancer-Linked Mutations
Lukas Dow, Ph.D., is using CRISPR technology to find better ways to fight cancer by editing the genome.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
Testing a Signal-Inhibiting Drug on Tumors with Specific Mutations
A new drug for certain tumor mutations is being tested in a type of clinical trial called a basket trial, which matches tumor genetics and drugs.
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
Adding Focused Radiation to Standard Pancreatic Cancer Treatment
Researchers are using IORT–intraoperative radiation therapy–to treat pancreatic cancer that cannot be surgically removed.
ASCO Annual Conference: Highlights in Pancreatic Cancer Research
Dr. Allyson Ocean reviews some of the latest pancreatic cancer research results, including new treatments for some patients.
Pancreatic Cancer Research Highlights from ASCO GI 2025
Read about the pancreatic cancer research highlights from the ASCO GI 2025 conference, where treatments and quality-of-life were discussed.
Gut Reaction for Pancreatic Cancer
Dr. Florencia McAllister and her team are looking at the tumor microbiome to develop effective pancreatic cancer treatments.
Targeting the Undruggable KRAS Protein
Dr. Shubham Pant is focusing his research on effective treatments for the KRAS mutation, found in 90% of pancreatic cancers.